RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Societal CDMO Stock

Societal CDMO Net Income 2024

Societal CDMO Net Income

-9.16 M USD

Ticker

SCTL

ISIN

US75629F1093

WKN

A1XFAV

In 2024, Societal CDMO's profit amounted to -9.16 M USD, a -30.97% increase from the -13.27 M USD profit recorded in the previous year.

The Societal CDMO Net Income history

YEARNET INCOME (undefined USD)
2029e-
2028e-
2027e-
2026e4.31
2025e-6.47
2024e-9.16
2023-13.27
2022-19.88
2021-11.37
2020-27.5
2019-18.63
2018-79.72
2017-50.08
2016-30.21
20153.03
2014-17.4
2013-2.4
2012-1.95
2011-3.25

Societal CDMO Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Societal CDMO, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Societal CDMO from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Societal CDMO’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Societal CDMO. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Societal CDMO’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Societal CDMO’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Societal CDMO’s growth potential.

Societal CDMO Revenue, EBIT and net profit per share

DateSocietal CDMO RevenueSocietal CDMO EBITSocietal CDMO Net Income
2029e167.85 M undefined0 undefined0 undefined
2028e145.95 M undefined25.54 M undefined0 undefined
2027e126.92 M undefined19.04 M undefined0 undefined
2026e112.82 M undefined11.28 M undefined4.31 M undefined
2025e103.44 M undefined2.78 M undefined-6.47 M undefined
2024e96.82 M undefined-1.32 M undefined-9.16 M undefined
202394.64 M undefined-3.57 M undefined-13.27 M undefined
202290.21 M undefined280,000 undefined-19.88 M undefined
202175.36 M undefined410,000 undefined-11.37 M undefined
202066.5 M undefined-8.34 M undefined-27.5 M undefined
201999.22 M undefined23.63 M undefined-18.63 M undefined
201877.35 M undefined-54.04 M undefined-79.72 M undefined
201771.83 M undefined-40.31 M undefined-50.08 M undefined
201669.34 M undefined-25.77 M undefined-30.21 M undefined
201551.95 M undefined-6.97 M undefined3.03 M undefined
20140 undefined-11.87 M undefined-17.4 M undefined
20130 undefined-1.09 M undefined-2.4 M undefined
20120 undefined-880,000 undefined-1.95 M undefined
20110 undefined-2.31 M undefined-3.25 M undefined

Societal CDMO stock margins

The Societal CDMO margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Societal CDMO. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Societal CDMO.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Societal CDMO's sales revenue. A higher gross margin percentage indicates that the Societal CDMO retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Societal CDMO's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Societal CDMO's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Societal CDMO's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Societal CDMO. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Societal CDMO's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Societal CDMO Margin History

Societal CDMO Gross marginSocietal CDMO Profit marginSocietal CDMO EBIT marginSocietal CDMO Profit margin
2029e19.17 %0 %0 %
2028e19.17 %17.5 %0 %
2027e19.17 %15 %0 %
2026e19.17 %10 %3.82 %
2025e19.17 %2.69 %-6.25 %
2024e19.17 %-1.36 %-9.46 %
202319.17 %-3.78 %-14.03 %
202225.65 %0.31 %-22.04 %
202126.3 %0.54 %-15.09 %
202018.6 %-12.54 %-41.35 %
201948.62 %23.82 %-18.78 %
201844.2 %-69.86 %-103.06 %
201746.83 %-56.12 %-69.72 %
201646.42 %-37.16 %-43.57 %
201546.01 %-13.42 %5.83 %
201419.17 %0 %0 %
201319.17 %0 %0 %
201219.17 %0 %0 %
201119.17 %0 %0 %

Societal CDMO Aktienanalyse

What does Societal CDMO do?

Recro Pharma Inc. is a company operating in the biopharmaceutical industry, specializing in the development and marketing of innovative therapeutics. The company is based in Malvern, Pennsylvania, USA, and was founded in 2007. The history of Recro Pharma Inc. dates back to 1985, when the company was founded as ReceptoPharm. In 2008, it was renamed Recro Pharma Inc. to emphasize its focus on pharmaceutical activities. Since then, the company has made significant progress, including successful clinical trials and the introduction of innovative products. Recro Pharma follows a business model based on the development of therapeutics in the areas of pain management and anesthesia. The company aims to create solutions to alleviate pain in patients and improve their quality of life. Recro Pharma's goal is to bring high-quality products to the market that are distinguished by excellent safety, efficacy, and patient tolerance. Recro Pharma's product range currently includes two main areas. Firstly, the company has launched its medication Meloxicam for pain treatment in adults. Secondly, it has developed and distributes a portfolio of anesthesia-related therapeutics through its subsidiary Lumendi LLC. Meloxicam is a non-steroidal anti-inflammatory drug used for pain relief in adults. The medication is available in various forms such as tablets and capsules and is used in both hospital and outpatient care. Lumendi LLC specializes in the development and distribution of anesthesia-related therapeutics. The company's products include those for intubation and muscle relaxation in surgical procedures, as well as anesthesia for pain management. Lumendi's goal is to create innovative solutions to improve medical practice and shorten hospital stays. Recro Pharma Inc. aims to expand its product range through the development of further innovative solutions. The company continues to invest in research and development to develop new products and strengthen its position in the market. In 2020, Recro Pharma Inc. received FDA approval for the product IV Meloxicam. This is an intravenous form of the drug Meloxicam used for pain treatment in adults. This is a significant milestone for the company as it is now able to offer an alternative form of the medication. Recro Pharma Inc. has established itself as a significant player in the biopharmaceutical industry. The company aspires to further strengthen its position in the market and create innovative solutions to improve medical practice. With its high-quality products, Recro Pharma contributes to alleviating patients' pain and improving their quality of life. Societal CDMO ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Societal CDMO's Profit Margins

The profit margins of Societal CDMO represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Societal CDMO's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Societal CDMO's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Societal CDMO's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Societal CDMO’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Societal CDMO stock

How much profit has Societal CDMO made this year?

Societal CDMO has made -9.16 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -30.97% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Societal CDMO publish its earnings?

Societal CDMO publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Societal CDMO?

The profits of Societal CDMO are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Societal CDMO?

You can learn more about the earnings of Societal CDMO by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Societal CDMO pay?

Over the past 12 months, Societal CDMO paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Societal CDMO is expected to pay a dividend of 0 USD.

What is the dividend yield of Societal CDMO?

The current dividend yield of Societal CDMO is .

When does Societal CDMO pay dividends?

Societal CDMO pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Societal CDMO?

Societal CDMO paid dividends every year for the past 0 years.

What is the dividend of Societal CDMO?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Societal CDMO located?

Societal CDMO is assigned to the 'Health' sector.

Wann musste ich die Aktien von Societal CDMO kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Societal CDMO from 8/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/11/2024.

When did Societal CDMO pay the last dividend?

The last dividend was paid out on 8/11/2024.

What was the dividend of Societal CDMO in the year 2023?

In the year 2023, Societal CDMO distributed 0 USD as dividends.

In which currency does Societal CDMO pay out the dividend?

The dividends of Societal CDMO are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Societal CDMO

Our stock analysis for Societal CDMO Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Societal CDMO Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.